Conformis

Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology

Conformis’ Patient-Specific Knee Implant Technology Is Complemented by New 3D-designed Hip System Launched in November 2019 BILLERICA, Mass., Jan. 30,

VIEW POST »

Latest Conformis Knee Implant News

News Overview

New Clinical Study Finds Bilateral Knee Patients Prefer Conformis’ Fully Personalized Solution Over Competitive Off-the-Shelf Implants by a Factor of Over 10 to 1

Study included only patients with a fully personalized Conformis implant in one knee after previously receiving a competitive off-the-shelf implant

Conformis iTotal® CR Knee Replacement System Awarded “7A” Performance Rating from the U.K.’s Orthopaedic Data Evaluation Panel 

Independently verified assessment of the performance of the fully personalized iTotal CR system over a 7-year period confirms that it meets the panel’s demanding standards 

Conformis, Inc. Announces Strong Clinical Study Results for Its Personalized Knee Implants

A retrospective review of 540 procedures performed demonstrated 98.5% Implant Survivorship and 89.0% Patient Satisfaction for the Conformis patient-specific iTotal®

Conformis, Inc. Announces 510(k) Clearance for Identity Imprint™ Knee Replacement System

Leveraging Conformis’ extensive library of personalized knee design data and patient images, Identity Imprint is designed to match patients’ anatomy

Clinical Study: Patient-Specific Total Knee Replacement with Conformis Technology Is More Cost-Effective Than with Leading Off-the-Shelf Implants

Independent, retrospective review of 2016-2019 surgeon data by University of Washington researchers demonstrates that Conformis iTotal® knee replacement implants enable

90% Patient Satisfaction Reported in Peer-Reviewed Clinical Study of Conformis iTotal PS Knee Replacements

Clinical research published online in July 2020 in The Journal of Bone and Joint Surgery Reviews found that the patients

Conformis Announces 510(k) Clearance for iTotal® Identity PS

iTotal® Identity PS joins iTotal® Identity CR as the latest personalized knee technology from Conformis BILLERICA, Mass., June 22, 2020 (GLOBE NEWSWIRE)

Prestigious Klee Family Foundation Prize 2020 Awarded for Outstanding Scientific Work Identifying Patient-Specific Approach as Better Way to Optimize Knee Implant Design

Dr. Malte Asseln awarded annual prize by German Society for Biomedical Engineering at the VDE Association and the Klee Family

Conformis Achieves 100,000 Implant Milestone for Patient-Specific Knee Replacement Technology

Conformis’ Patient-Specific Knee Implant Technology Is Complemented by New 3D-designed Hip System Launched in November 2019 BILLERICA, Mass., Jan. 30,

Conformis and Stryker Execute Development, License and Distribution Agreements

Deal to Cover Patient-Specific Instrumentation Used in Knee Arthroplasty BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ: CFMS), a medical technology

New Peer Reviewed Data Supports Use of Conformis Customized Knee Implants to Match Anatomic Variability in Patients

BILLERICA, Mass., April 23, 2019 (GLOBE NEWSWIRE) — Conformis Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit

The 3D designed Conformis Hip System Announced at the 2019 AAOS conference

Designed to enhance operational efficiency for the surgeon and improve patient outcomes, the Conformis Hip System is the most advanced,

Customized Knee Implants Drive Significant Cost Savings in a Medicare Population – Abstract Presented at Annual Knee Society Meeting

12-month average spending was $1,697 less for Medicare Fee for Service members who received customized implants compared to members who

Conformis Announces Settlement of Patent Dispute with Smith & Nephew

Conformis to Receive $10.5 Million for Non-Exclusive License to Patient-Specific Instrument Patents for use with off-the-shelf knee implants BILLERICA, Mass.,

Conformis announces election of Carrie Bienkowski to its Board of Directors

BILLERICA, Mass., August 2, 2018 (GLOBE NEWSWIRE) – Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit

Conformis Announces the first 3D Total Hip Replacement Surgeries performed at JFK Medical Center in Florida

The most advanced, patient conforming hip replacement system designed to enhance operational efficiency for the surgeon and improve patient outcomes

Peer Reviewed Results: Conformis Patient Specific iTotal CR Achieves Better Rotational Alignment and Tibial Fit Compared to Off-the-Shelf Implants

Manuscript highlights the intraoperative compromises of fit vs. rotation with the legacy off-the-shelf knee implants BILLERICA, Mass., June 25, 2018

The Post and Courier, Charleston SC - As knee replacements continue to rise, so does the demand for custom, 3-D technology

Bonnie Dan’s knee pain became so severe over the years that she found it difficult to accomplish everyday tasks like

KOMO News, Kirkland WA - 3D printing offers new tech for replacement knees

Architect Joe Herr spoke with KOMO News in Kirkland, Washington about how his eye for construction helped him to understand

MD+DI - 3D Printing Is Hot Topic for Cleveland Clinic

Several healthcare companies have already invested heavily in the 3D printing space. Conformis has developed its business around 3D printing

Boston Globe - "Boomers are going bionic, and they want joint replacements to let them do it all"

“The baby boomer explosion is a big deal in health care,” said Conformis chief executive Mark Augusti. “Technology has to

Robin Robertson of Healthy Knees - Radio Interview with KGMI Morning News

http://kgmi.com/podcasts/kgmi-morning-news-extra-for-3-28-18-custom-knee-replacement/

New Implant Technology, A New Twist On Knee Replacement

The Cape Cod Chronicle: ConforMIS, is breaking new ground in the field of knee replacements by offering something never seen before: customized knee implants designed and manufactured for each individual patient, with no two quite alike.

Four-Year Data from the UK National Joint Registry Highlights High Survivorship in Patients Treated with the Conformis iTotal CR

Data Shows a Low Cumulative Percent Revision of 0.5% for Conformis Patients vs 1.9% for all Total Knee Replacement Patients

Conformis iTotal CR Knee Replacement System Awarded “3A” Rating from the Orthopaedic Data Evaluation Panel in the United Kingdom

Rating highlights positive three-year survivorship following total knee arthroplasty BILLERICA, Mass., March 01, 2018 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS),

Fox 13 Tampa Florida - Knee replacements now custom-made for patients

Medi-Weightloss CEO Ed Kaloust talks with his surgeon, Dr. Brian Palumbo, about golfing after his Conformis knee http://www.fox13news.com/health/knee-replacements-now-custom-made-for-patients 

Orthopedics This Week - Positive results for Conformis' iTotal CR knee system

Orthopedics This Week reports on Dr. Gary Levengood’s latest study published in the Journal of Knee Surgery that investigated the ability

11 Alive Atlanta Georgia - 3D technology offers alternative for knee replacement patients

Longtime athlete Glenn Sikes and his stepfather Jarrett Freeland both had their knees replaced with Conformis. Here, they speak with

Health + Fitness Memphis - Gail Blayde and Dr. Peter Lindy

https://memphishealthandfitness.com/2018/02/01/new-knees-replacement-technology-for-more-mobility/

Conformis Announces Publication of Results published in the peer-reviewed Journal of Knee Surgery showing 100% of patients treated with iTotal CR achieve mechanical alignment in target range of +/- 3°

BILLERICA, Mass., Jan. 04, 2018 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants designed

News Channel 5 Nashville - Will Kurtz, MD and Mike Plunkett

Every year, more than 600,000 people have knee-replacement surgery. Now, 3D printing is helping patients regain their mobility.

Leader of Johnson & Johnson 3D Printing Center of Excellence Outlines Advantages of Customized Knee Implants

Monday, 10/16/17 Orthopedic Industry Researches Additive Manufacturing and Customized Implants, While Body of Positive Clinical Results Related to Conformis Customized

Press Republican, New York - Phillip Volk, MD and Denise Cross

http://www.pressrepublican.com/news/lifestyles/patients-find-lives-changed-by-new-knees/article_8d12c81e-2efb-5022-b842-80d9c45a5992.html

Conformis Names Dan Krupp Senior Vice President U.S. Sales

BILLERICA, Mass., July 11, 2017 (GLOBE NEWSWIRE) — Conformis, Inc. (NASDAQ:CFMS), a medical technology company that offers joint replacement implants

Lake & Sumter Style, Florida - John Williams, MD and Bill Eggert

https://www.lakeandsumterstyle.com/technically-speaking/

Conformis Announces FDA 510(k) Clearance for iTotal Hip System

New hip replacement implant system builds on Conformis’s customized knee replacement technology and positions Company to expand in global orthopedics

Orthopedics This Week - Conformis 3D Technology Improves TKA

https://ryortho.com/breaking/conformis-3d-technology-improves-tka/

Conformis Announces the Publication of Clinical and Economic Study Comparing Customized Total Knee Replacement Implants to Off-the-Shelf Total Knee Replacement Implants

Data published in Arthroplasty Today demonstrate that patients treated with customized knee implants had significantly lower adverse event rates and

New Hampshire Union Leader - Thomas Marks, MD and Esther Cohen

http://www.unionleader.com/silver-linings/derry-surgeon-says-replacement-knees-made-with-3-d-technology-cut-surgery-rehab-time-20170613

Las Vegas Sun - Robert Tait, MD and Simon Pulitzer

https://lasvegassun.com/news/2017/jun/01/3-d-printing-becoming-more-routine-in-knee-replace/

Click 2 Houston - Matthew Pombo, MD and Amanda Fair-Evans

https://www.click2houston.com/news/investigates/personalize-your-knee-replacement-new-procedure-helps-surgeons-customize-new-knees

KSAT 12 News, Texas - Matthew Pombo, MD and Amanda Fair-Evans

https://www.ksat.com/health/build-your-own-3d-knee

Orthopedic Design & Technology - Sharing The Patient's Experience

https://www.odtmag.com/issues/2017-05-01/view_editorials/sharing-the-patients-experience/

SeacoastOnline - Moby Parsons, MD

http://www.fosters.com/news/20170505/parsons-joins-portsmouth-regional-hospital

WHAS News Kentucky - Ernest Eggers, MD and Rick Robey

http://www.whas11.com/entertainment/television/great-day-live/uk-legend-rick-robey-back-in-action-thanks-to-louisville-orthopedic/434896785

Conformis Announces Positive Results from Customized iTotal PS Total Knee Replacement Comparative Study

First study of iTotal PS customized implants demonstrated more normal kinematics compared with leading off-the-shelf implants Bedford, Mass. – April 12,

Conformis, Inc. Announces Election of Philip W. Johnston to its Board of Directors

Bedford, Mass. – March 31, 2017 (GLOBE NEWSWIRE) – Conformis, Inc. (NASDAQ:CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology

Indy Star - Todd Midla, MD

https://www.indystar.com/videos/news/2017/03/09/3-d-technology-used-knee-replacement/98552876/

ConforMIS Names Industry Veteran Mark Augusti President and Chief Executive Officer

BEDFORD, Mass., Oct. 24, 2016 (GLOBE NEWSWIRE) — ConforMIS Inc. (NASDAQ:CFMS), a medical technology company that develops, manufactures and sells

Conformis Announces Publication of Clinical Study Demonstrating iTotal CR Customized Implants Better Approximate Normal Knee Motion When Compared to a Leading Off-the-Shelf Total Knee Implant

Head-to-head study published in The Journal of Arthroplasty also demonstrated improved mid-flexion stability Bedford, Mass. – October 17, 2016 – Conformis, Inc. (NASDAQ:CFMS),

Conformis Announces Sale of Over 50,000 Customized Knee Implants

To Commemorate Milestone, Conformis to Host Inaugural Patient Ambassador Summit Bedford, Mass. – October 4, 2016 – Conformis, Inc. (NASDAQ:CFMS), a medical technology

Clinical Studies Demonstrate Conformis iTotal CR Customized Knee Implants Provide Superior Outcomes and Potential for Economic Savings

New clinical study demonstrates potential for Conformis iTotal CR customized knee implants to contribute cost savings across episode of care

Study Finds High Satisfaction Amongst Patients with Conformis Customized Total Knee Replacements

New data corroborates previous study that demonstrated higher satisfaction with iTotal CR than traditional, off-the-shelf implants Bedford, Mass. – July 6,

Conformis iTotal® PS Customized Knee Replacement Honored as 2016 Gold Stevie® Award Winner

Accolade recognizes innovation in first-ever customized posterior-stabilized total knee replacement system Bedford, Mass. – June 21, 2016 – Conformis, Inc. (NASDAQ: CFMS), a

Conformis Announces Positive Results from Clinical Studies Comparing the Conformis iTotal® CR to Leading “Off-The-Shelf” Total Knee Replacement Products

Multiple studies presented at BASK Annual Meeting support improved patient outcomes with Conformis customized total and partial knee replacements Bedford,

Conformis Announces Full Commercial Launch of iTotal® PS, the Only Customized Posterior Stabilized Total Knee Replacement System

iTotal PS nearly triples the available market for Conformis Bedford, Mass. – March 2, 2016 – Conformis, Inc. (NASDAQ:CFMS), a medical technology company

Conformis Announces Results of Multiple Studies of its Customized Knee Replacements Presented at the 2015 Pan Pacific International Congress for Joint Reconstruction

Conformis’s customized iTotal CR knee replacements demonstrate superior functional outcomes compared to off-the-shelf knee replacements in multiple studies Bedford, Mass.

Conformis Closes Initial Public Offering

Bedford, Mass. – July 7, 2015 – Conformis, Inc. (NASDAQ: CFMS) announced today the closing of its initial public offering of 10,350,000 shares

Conformis CEO: Getting A Knee Up (Mad Money, CNBC)

Click here to read the full show recap on TheStreet.com Conformis is not responsible for the contents or reliability of

Conformis Announces Pricing of Its Initial Public Offering

Bedford, Mass. – June 30, 2015 – Conformis, Inc. announced today the pricing of its initial public offering of 9,000,000 shares of common

Conformis Announces Settlement of Patent Infringement Lawsuits

Licenses Expand the Footprint of Conformis’ Patented Patient-Specific Instrumentation Technology Bedford, Mass. – April 17, 2015 – Conformis, Inc., a medical technology company

Conformis Announces Latest Generation iTotal Customized Total Knee Replacement Implant System

Upgrades include improvements to customized implants and iJig patient-specific instruments Bedford, Mass. – March 24, 2015 – Conformis, Inc., a medical technology company

Conformis to Present at J.P. Morgan 33rd Annual Healthcare Conference

Bedford, Mass. – January 5, 2015 – Conformis, Inc., a medical device company providing the only truly customized knee replacement implant systems, today

Conformis Ranked Number One in Patent Power Among Medical Device Companies

Honor recognizes strength and impact of Conformis’ broad and expanding patent portfolio for technology related to company’s customized orthopedic implants

New Clinical Studies Demonstrate Conformis' Customized Knee Implants Have More Natural Knee Motion, Greater Stability and Better Range of Motion When Compared to Off-the-Shelf Knee Replacements

Two in vivo studies evaluate motion patterns and kinematics in the knee for the first time using real-time mobile x-ray

Conformis Customized iTotal® Knee Replacement Shown to Significantly Reduce Risk of Adverse Events and Improve Discharge Status with No Increase in Hospital Costs Compared to Off-the-Shelf Implants

Clinical results of patients treated with Conformis iTotal® customized knee implants presented at the 2014 International Congress for Joint Reconstruction

Conformis’ Customized Total Knee Implants Demonstrate Normal Feel, Zero Blood Transfusions and High Patient Satisfaction

Results from the 2014 British Association for Surgery of the Knee (BASK) meeting highlight excellent patient satisfaction, normal feel and

Conformis to Present at the Canaccord Genuity Musculoskeletal Conference

Bedford, Mass. – March 5, 2014 – Conformis, Inc., a medical device company pioneering patient-specific orthopedic implants, will present at the Canaccord

Conformis to Present at the 32nd Annual J.P. Morgan Healthcare Conference

Bedford, Mass. – January 7, 2014 – Conformis, Inc., a medical device company pioneering patient-specific orthopedic implants, will present at the 32nd

Conformis Achieves Significant Funding Milestone with $167.7 Million in Series E Financing

Latest funding to support ongoing commercial expansion of iTotal® G2 rollout, the industry’s only patient-specific total knee implant G2 rollout

Conformis Appoints Senior Vice President, Operations

Matthew Scott takes leadership on scaling operations to meet growing demand for Conformis‘ patient-specific technology Conformis, Inc., a privately held

Conformis to Present at Canaccord Genuity and Morgan Stanley Conferences

Bedford, Mass. – March 15, 2013 – Conformis, Inc., a privately held medical device company pioneering patient-specific orthopedic implants, announced today its participation

Conformis to Present at 31st Annual JP Morgan Healthcare Conference

San Francisco, Cali. – January 9, 2013 – Conformis, Inc., a privately held medical device company pioneering patient-specific orthopedic implants for the

Conformis Appoints New Chief Financial Officer

Peter Traynor Brings Over 30 Years of Industry Experience Bedford, Mass. – November 12, 2012 – Conformis, Inc., a privately held medical

Conformis Announces New Corporate Headquarters to Accommodate Substantial Growth, Increased Job Creation and Scaled Manufacturing

Existing Burlington space to remain as company’s first standalone manufacturing facility Bedford, Mass. – November 1, 2012 – Conformis, Inc., a privately held

Conformis Launches Next Generation of Only Patient-Specific Total Knee Replacement Implant System Available on Market

iTotal platform designed with specific features to address potential causes of patient dissatisfaction Burlington, Mass. – October 3, 2012 – Conformis,

Conformis iTotal® CR Knee Replacement System Wins Silver in 2012 Medical Design Excellence Awards

iTotal CR Recognized as One of the Most Innovative New Medical Devices Burlington, Mass. – May 25, 2012 – Privately-held Conformis, Inc. today

Conformis Files for Interference Proceeding Against Imperial Innovations Group

Burlington, Mass. – March 21, 2012 – Conformis, Inc. filed documents to initiate an interference proceeding in the United States Patent and

Conformis Expands Intellectual Patent Portfolio with 22 Issued Patents

Company Grows Leading Patent Position in Patient-Specific Implants and Patient-Specific Instrumentation Burlington, Mass. – February 6, 2012 – Conformis, Inc. today

Conformis Reaches Funding Milestone with $89 Million in Series E Financing

One of the Largest Fundraises by a Private Healthcare Company in 2011 Will Be Used to Support Commercial Expansion, Manufacturing

Mahmoud Hafez Joins Conformis Scientific Advisory Board to Advance Image to Implant Technology

Prof. Hafez brings rich history of development in patient specific orthopaedics to Conformis team Burlington, Mass.— Sept 15, 2011 — Today, Conformis

Knee Replacement Manufacturer Conformis to Expand Using MassDevelopment Technology

MassDevelopment has provided a $1,445,000 loan from the Emerging Technology Fund to Burlington’s Conformis, Inc., a privately held medical device company

Conformis Selected as Winner for 2011 American Technology Award

iTotal Knee Replacement System Recognized for Outstanding Achievement Burlington, Mass. – June 16, 2011 – Conformis, Inc. today announced that its iTotal® Knee Replacement

Conformis Receives CE Mark Certification for iTotal CR Patient-Specific Total Knee Resurfacing System

Conformis Receives CE Mark Certification for iTotal CR Patient-Specific Total Knee Resurfacing System Certification Clears Way for Introduction in Europe

Conformis Announces Completion of the First iTotal CR Knee Resurfacing System Surgeries

Conformis Announces Completion of the First iTotal CR Knee Resurfacing System Surgeries First Patient Surgeries with Customized Alternative to Traditional

Klaus Radermacher Joins Conformis Scientific Advisory Board to Advance True Patient Specific Implant Platform

Conformis, Inc. leverages Professor Radermacher’s expertise for the next steps in patient specific technology innovation Burlington, Mass.— April 18, 2011 —

FDA Clears First Patient-Specific Implant System for Total Knee Replacement

Customized Approach Saves Bone, Improves Fit, and Reproduces Normal Anatomy Burlington, Mass.— February 3, 2011 — Conformis has received 510(k) clearance from the

Webcast from Conformis on Revolutionary Bicompartmental Knee Resurfacing Implant Now Available on ORlive.com, YouTube

View the interviews from leading orthopedic experts to learn more Burlington, Mass. — January 6, 2011 — On December 14th at 7:00pm EDT, OR-Live broadcasted a

Conformis Launches Next Generation of the Only Patient-specific Bicompartmental Knee Resurfacing System on the Market

iDuo G2 Provides Less Invasive Alternative to Total Knee Replacement Burlington, Mass. — November 4, 2010 — Conformis announced today the commercial availability

Conformis Receives CE Certification for iUni® G2 Patient-Specific Unicompartmental Knee Resurfacing Implant

iUni G2 Provides Superior Advantages to Patients, Surgeons, and Hospitals Including Minimal Bone Resection and Simplified Surgery Burlington, Mass. –

Conformis Launches iUni® G2 Next Generation Platform for the Only Patient-Specific Unicompartmental Knee Replacement

Burlington, Mass. – December 14, 2009 Surgeon Feedback and Advanced Engineering Combine to Create a Wear Optimized Implant with an

OR Live to Webcast Personalized Partial Knee Resurfacing Procedure

Burlington, Mass. – October 27, 2009 – At 6 p.m. CST on November 10, Foundation Surgical Hospital will present a live webcast of

Conformis Raises $50 Million from Global Investors

Burlington, Mass. – July 13, 2009 – In its largest round of funding to date, privately-held medical-device company Conformis, Inc. raised

Conformis Receives CE Mark for the First and Only Personalized Bicompartmental Knee Resurfacing System

Burlington, Mass. – June 23, 2009 – Conformis, Inc., a privately held orthopedics company that develops and commercializes personalized, minimally invasive

Conformis Wins Medical Design Excellence Award

Premier award for medical technology design goes to company’s customized implants for partial knee replacement Burlington, Mass.— April 6, 2009—Two

Conformis Expands Executive Team with Addition of Medical Device Industry Veterans

With More than 1100 Procedures To-Date, Conformis Continues To Gain Momentum In the Orthopedics Market Burlington, Mass.— March 30, 2009— Conformis, Inc.,

Conformis Maintains Commitment to Advancing Patient-Specific Solutions by Expanding Scientific Advisory Board

New Additions Enhance World Class Expertise in Total and Partial Knee Systems Burlington, Mass. — February 23, 2009 – Conformis, Inc., a

Conformis Expands Scientific Advisory Board

Dr. Richard D. Scott Brings World-Renowned Partial Knee Expertise to Board Burlington , Mass. – December 9, 2008 – Conformis, Inc., a

OR-Live to Webcast Patient-Specific Bicompartmental Knee Resurfacing Surgery

Brigham and Women’s Orthopedic Surgeons to Perform Live iDuo® Procedure Burlington , Mass. — October 6, 2008 — Conformis, Inc., a privately held

Conformis, Inc. Is Named the Winner of the 2008 North American Frost & Sullivan Award for Medical Device Healthcare Innovation

Burlington , Mass. — August 25, 2008 — Conformis. Inc. has been named the winner of the 2008 North AmericanFrost

Conformis, Inc. Launches First Patient-Specific, Bicompartmental Knee Resurfacing System on the Market

Burlington, Mass.— August 4, 2008—Conformis, Inc., a privately held orthopedics company that develops and commercializes minimally invasive medical devices for

Advancements in Patient-Specific Knee Surgery Technique Reported in the June Issue of Orthopedics Today

Burlington, Mass. – June 11, 2008 – Conformis, Inc., a privately held company that develops and commercializes minimally invasive orthopedic devices,

Conformis Named 2008 Red Herring North America 100 Winner

Burlington, Mass. – May 19, 2008 – Conformis, Inc., a privately held company that develops and commercializes minimally invasive medical devices for

Conformis Completes Executive Team With Addition of CFO

Burlington, Mass. – May 5, 2008 – Conformis, Inc., a privately held company that develops and commercializes minimally invasive medical devices for

Conformis, Inc. Appoints Medical Device Veteran to Chief Operating Officer

Burlington, Mass. – March 24, 2008 – Conformis, Inc., a privately held company that develops and commercializes minimally invasive medical devices for the

Conformis to Present at Canaccord Adams Orthopedics Conference

Burlington, Mass. – February 26, 2008 – Conformis, Inc., a privately held company that develops and commercializes minimally invasive medical devices for the

Conformis Introduces the First Patient-Specific Unicompartmental Knee Resurfacing Implant on the Market

Ground-breaking Partial Knee Implant and Instrumentation Now Available Burlington, Mass. – February 25, 2008 – Conformis, Inc., a privately held orthopedics company

Conformis Bolsters Management Team

Company Appoints Philipp Lang, MD, MBA to Chief Executive Officer Burlington, Mass.— January 28, 2008—Conformis, Inc., a privately held company

iUni™ and iJig™ Approved in All European Union Markets

Conformis, Inc. receives CE Mark Certification for Minimally Invasive Patient Specific Implants and Instruments Burlington , Mass. – January 17, 2008

30-Year Johnson & Johnson Veteran Joins Conformis' Renowned Executive Team

John Slamin to Lead Engineering Efforts for Next-Generation Medical Device Company Burlington, Mass.— November 6, 2007 —Conformis, Inc., a privately held

Conformis Moves Headquarters to Expanded Facilities in Burlington, MA

BURLINGTON, MA, USA – August 30, 2007 – Conformis, a privately held medical device company dedicated to developing and marketing patient-specific
Load more posts

Ziehen Sie Conformis Deutschland in Betracht?

Füllen Sie das folgende Formular aus, um weitere Informationen von Conformis anzufordern

Kontakt: info.de@conformis.com